Member Info for chester18

OK thank you, after an initial pause by the market the cessation of "differential facts" has in fact resulted in the share price now moving back up ......

All shareholders will be relieved to hear...

Chester.

I've just noticed that when you two Matadors argue the price goes down and when your are not going back and forth at each other the price goes up.

So in the interest of "shareholder value" could you please stop !!

................. : )

Chester.

I recently had the same thoughts when I bought 150k @ 16p and at 20p sp thats £6k up in price already.
Looking at what is come in the next 2 / 3 months the probability on announcement of the MRE the price will be a lot higher than today.

Just my opinion based on all the very positive factors that we know

Chester.

If we are not accepted into the GDXJ this quarter then there is always the next one.
If we are included then fantastic the SP should rise further due to that.
If we don't get in and the price does drop 20%, as you are suggesting back to around 16p, then surely its time to buy.....

So win / win in my book. No way am I gambling by selling to buy back because there is still so much upside that can happen very quickly as we have just witnessed this last couple of weeks.

Chester.

Joe

That is exactly the kind of thinking that makes the difference. GH has shown he is a clinical businessman, he understands the impacts of news on the SP.
So I think you are absolutely spot on, if the three holes, we know, have been drilled at Scallywag were just rocks he would definitely got out ahead of these results which are exceptional.

Good post and lateral thinking

Chester

With those results tonight and the 4 - 6 weeks time lag as to what is actually known the MRE is going to be bigger than most of us dare hope for.

If the SP goes down tomorrow it will ruin my belief that the general intellect of this board is very High. So I very much hope the direction of the SP is positive tomorrow or I'm going to become very sceptical ...... : )

Chester.

Hi Fredd1eboy

Well done with your faith in VAL, I was tempted to take a position about 6 weeks ago but couldn't press the buy button. Good to see you back here and would be karma if you do well this time around. The exosomes could be a big play while the RP platform is being validated through 2021.

I agree that this is already oversold but 80 to 85p 'buy in' is still on the cards, especially if the AGM is a damp squib.

Chester

That was an excellent rise without being pushed by an RNS, great while it lasted but makes me excited for when we do actually here about the Mabs potential deal or Covidity labs data or SCIB1 Combi re-start date.....

I'm not a trader but at 12.2p I could have taken a good 6k profit on what I bought last Friday so I fully understand why people take the 'bird in the hand', no problem with that.

I'm here for the big news end 2021 / early 2022. Todays excitement is just a small prelude to what may be coming our way very shortly.

Now whats Rampy about that........ : )

Chester.

Well what an amazing turn-a-round, for those that have been here a while you know that I have been overly zealous in my positivity of Scancells scientific technology, the strong IP, the even stronger Patents and the proof of pathway in the SCIB1 Melanoma trial.

Many a dark day with delays, not all down to Scancell. Anyhow I've recklessly continued buying the shares and today is an excellent first rung in the progression ladder that positive RNS announcements are going to bring.

The over subscribed Open Offer eluded to the pent up demand for these shares, looks like it just needed some confidence in the share which was assured with the Covidity funding announcement. I'm now hoping that this means that the sentiment for Scancells future prospects is begining to change for the better.

With the potential of a good positive RNS landing in the next few weeks "whats not to like".......

Chester.

I have posted this before but its very relevant to Scancells journey ....

Steve Jobs said in an interview :

"The place where Apple has been standing for the past two decades is exactly where computer technology and the consumer electronics markets are converging. So its not like we're having to cross the river to go somewhere else; the other side of the river is coming to us"

Just substitute Scancell and 'Oncology / Cancer Vaccine Science'.

Chester.

It wasn't that long ago that 'Cancer Vaccines' were dirty words in the opinion of Big Pharma.

How things have changed.....

Chester

Hi Mushroomkid

There is something very pleasant about walking on that upper deck, the whole historic feel to it and the worn wooden construction. It does feel very grand.
You can also go up onto the City Wall and walk around the entire city, definitely worth a train ride and a stay over.

Chester.

@Droverman

Thanks for the info regarding the drilling in the SW. I must have missed that post by reddirt.
Am I correct that GGP or NCM have never reported on that SW drill site ?

And yes Chester is fantastic walled city complete with the Medieval shopping streets 'The Rows'.
A must visit for anyone who has never been to see them.

Now live on the Cambs / Norfolk boarder.

Cheers, Chester......

@Hydrogen

Thank you for your reply.

I'm really looking forward to having some concrete information about that SW area and if as you say it deep drilling under the SE area, well they are still at it and at one point went away and came back. Not a word over the last two or three reports so it is intriguing until we know. We should have a few infill holes as well plus an updated version of whats being found in the NW.

Oh, plus if they have gone deeper...

Chester.

Is there no one on the board that has a view about what we may hear or what to hear on Wednesday Night ?

Apart from some news as to what and why have they been drilling in the South West area for on and off 3 months, are there any other outstanding drilling cores that we are eagerly awaiting for results of ?

Anything North West or Depth that would really boost our attention ?

Chester.

"Positive thoughts and stating facts are not all about advertising to buy sclp shares, this is now the reality of our journey forwards".

The recognition and regard for Scancells patented science platforms is just about to start to rise. These last 2 to 3 years have been difficult as we kept on saying we needed patience, well that we did and needed quite a bit. Seeing the SP languish at below 5p has been difficult to stomach at times but now finally we have some solid ground to reaffirm our faith in their cancer vaccines, Mabs programmes and now the Covidity Platform.

A Ten Million pounds investment by Redmile, a well respected bio-pharma investor from San Francisco who has vetted and found Scancell to be a worthy recipient (of a not so small a chunk) of its carefully managed fund.

Vulpes Investment Fund looked into Scancell for 12 months during 2018 / 19 doing a very deep dive 'Due Dilligence' on all the data to hand including time spent with staff in the labs, which has resulted in them investing for a second time and have now put in a total of just over £4m.

Innovate UK have accepted the data presented by the Covidity consortium and found it compelling enough to award funding of £2.7m and £2m of that has gone to Scancell who are doing all the heavy lifting.

We have our first AvidiMab collaboration looking like its going to turn into the first of many potential commercial agreements for Glycan Mabs and or AvidiMab.

We have two approved Cancer Vaccine clinical trials in the UK and the US that are to be started soon (CV-19 permitting) and the dates for those trials will cause even more interest in Scancell Holding PLC.

So as I have said before,

"what is there to not like about Scancells future prospects".

Chester.

OK I'm going for £9.00 a share when MODI1 has proven it disposes of the first four cancer candidates and is set up to ready to destroy another 11.
When SCIB1 / Combi hits 80% success rate.
When AvidiMab, Glycan Mabs and Mab2811 are all out on 50 or 60 licenses.
When a successfully proven Covidity has moved on to other viruses and the delivery mechanism has been also out licensed.
When SCIB2, MODI2 AND MODI3 are all in the clinic.

So in quite a few years from now,
but in the words of the Great Bard himself ...

" verily quite doable, my dear Yorick"

Chester.

Apart from some news as to what and why have they been drilling in the South West area for on and off 3 months, are there any other outstanding drilling cores that we are eagerly awaiting for results of ?

Anything North West or Depth that would really boost our attention ?

Need to know roughly how many beers to have in the fridge ..... : ]

Chester.

Hi TomE

With the possibility of two SP moving events this week its very difficult to know.

If the update on the drill cores is anywhere above the Havieron 'norm' or we are given news that definitely increases the total tonnage of mineralisation, then that on its own will push the sp towards 20p.

If its announced that GGP have been accepted into the GDXJ this quarter that will also move us towards 20p on its own.

Both in the same week .......... nail your hat cos its gonna blow at bit ...... : )

Chester;

The recognition and regard for Scancells patented science platforms is just about to start to rise. These last 2 to 3 years have been difficult as we kept on saying we needed patience, well that we did and needed quite a bit. Seeing the SP languish at below 5p has been difficult to stomach at times but now finally we have some solid ground to reaffirm our faith in their cancer vaccines, Mabs programmes and now the Covidity Platform.

A Ten Million pounds investment by Redmile, a well respected bio-pharma investor from San Francisco who has vetted and found Scancell to be a worthy recipient (of a not so small a chunk) of its carefully managed fund.

Vulpes Investment Fund looked into Scancell for 12 months during 2018 / 19 doing a very deep dive 'Due Dilligence' on all the data to hand including time spent with staff in the labs, which has resulted in them investing for a second time and have now put in a total of just over £4m.

Innovate UK have accepted the data presented by the Covidity consortium and found it compelling enough to award funding of £2.7m and £2m of that has gone to Scancell who are doing all the heavy lifting.

We have our first AvidiMab collaboration looking like its going to turn into the first of many potential commercial agreements for Glycan Mabs and or AvidiMab.

We have two approved Cancer Vaccine clinical trials in the UK and the US that are to be started soon (CV-19 permitting) and the dates for those trials will cause even more interest in Scancell Holding PLC.

So as I have said before,

"what is there to not like about Scancells future prospects".

Chester.